In conclusion, immunohistochemistry against FOS/FOSB continues to represent the quickest, most cost-effective and reasonable diagnostic add-on to confirm the diagnosis of osteoblastoma and to exclude (osteoblastoma-like) osteosarcoma. Here, FOSB is linked to osteosarcoma.